Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2015, Article ID 438235, 8 pages
http://dx.doi.org/10.1155/2015/438235
Research Article

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments

1Bayer Healthcare Pharmaceuticals Inc., Whippany, NJ 07981, USA
2RTI Health Solutions, Research Triangle Park, NC 27709, USA

Received 29 September 2015; Accepted 12 November 2015

Academic Editor: Noriyuki Koibuchi

Copyright © 2015 Ateesha F. Mohamed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ateesha F. Mohamed, Juan Marcos González, and Angelyn Fairchild, “Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments,” Journal of Thyroid Research, vol. 2015, Article ID 438235, 8 pages, 2015. https://doi.org/10.1155/2015/438235.